Emcure Pharmaceuticals saw a significant 4% rise in its share price following impressive Q2 2024 earnings.
The company’s net profit surged by 39.83%, reaching ₹194.57 crore compared to ₹139.15 crore in Q2 2023. Additionally, Emcure reported a 20.38% increase in sales, totalling ₹2001.98 crores, up from ₹1663.09 crores in the same period last year.
As of 11:06 am, Emcure Pharmaceuticals shares were trading 4.46% higher at Rs 1,455.95 on the NSE.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
